Clinical Trial Update: PRISM Registry: Pseudobulbar Affect Registry Series

View source ↗

Summary

The PRISM Registry update for pseudobulbar affect has completed. Avanir Pharmaceuticals sponsored the registry, which collected PBA data across Alzheimer's dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Amyotrophic Lateral Sclerosis
• Multiple Sclerosis
• Parkinson Disease
• Stroke
• Traumatic Brain Injury

Drugs mentioned

• NUEDEXTA (DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE)

Snippet

Sponsor: Avanir Pharmaceuticals | Conditions: Alzheimer's Disease, Amyotrophic Lateral Sclerosis (ALS) | Status: COMPLETED